Effectiveness of topical caffeine in cataract prevention: Studies with galactose cataract

Molecular Vision

Volumn 16, Issue , 2010, Pages 2626-2633

  Varma, Shambhu D ^a   Kovtun, Svitlana ^a   Hegde, Kavita ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Criminal Justice and Applied Social and Political Sciences Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; GALACTOSE; GLUTATHIONE; HYDROXYPROPYLMETHYLCELLULOSE; PLACEBO; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR; ARTICLE; CATARACT; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; LENS; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, TOPICAL; ANIMALS; APOPTOSIS; AQUEOUS HUMOR; CAFFEINE; CATARACT; GALACTOSE; GLUTATHIONE; LENS, CRYSTALLINE; RATS;

EID: 78650779458     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Barone JJ, Robert HR. Caffeine consumption. Food Chem Toxicol 1996; 34:119-29.
2. Peters JM. Factors affecting caffeine toxicity: A Review of Literature. J Clin Pharm 1967; 7:131-41.
3. Maia L, de Mendonça A. Does caffeine intake protect from Alzheimer's disease? Eur J Neurol 2002; 9:377-82. [PMID: 12099922]
4. Lindsay J, Laurin D, Verreault R, Hebert R, Halliwell B, Hill GB, McDowell I. Risk Factors for Alzheimer's Disease: A Prospective Analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002; 156:445-53. [PMID: 12196314]
5. http://www.sciencedaily.com/releases/2009/01/090114200005.htm.
6. Ritchie K, Carriere I, De Mendonca A, Portet F, Dartigues JF, Rouaud JF, Barberger-Gateau O, Ancelin ML. The neuroprotective effects of caffeine. Neurology 2002; 69:536-45.
7. Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung K-H, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR. Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease. JAMA 2000; 283:2674-9. [PMID: 10819950]
8. Benedetti MD, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA. Smoking, alcohol, and coffee consumption preceding Parkinson's disease. Neurology 2000; 55:1350-8. [PMID: 11087780]
9. Jarvis MJ. Does caffeine intake enhance absolute levels of cognitive performance? Psychopharmacology (Berl) 1993; 110:45-52.
10. Johnson-Kozlow M, Kritz-Silverstein D, Barrett-Connor E, Morton D. Coffee Consumption and Cognitive Function among Older Adults. Am J Epidemiol 2002; 156:842-50. [PMID: 12397002]
11. Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ, Hu FB. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 2004; 140:1-8. [PMID: 14706966]
12. Huxley R, Lee CMY, Barzi F, Timmermeister L, Czernichow S, Perkovic V, Grobbee DE, Batty D, Woodward M. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus. Arch Intern Med 2009; 169:2053-63. [PMID: 20008687]
13. Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 2006; 166:1190-5. [PMID: 16772246]
14. Cadden IS, Partovi N, Yoshida EM. Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther 2007; 26:1-8. [PMID: 17555416]
15. Inoue M, Yoshimi I, Sobue T, Tsugane S. JPHC Study Group. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005; 97:293-300. [PMID: 15713964]
16. Rodriguez T, Altieri A, Chatenoud L, Gallus S, Bosetti C, Negri E, Franceschi S, Levi F, Talamini R, La Vecchia C. Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol 2004; 40:207-13. [PMID: 14693246]
17. Tavani A, Bertuzzi M, Talamini R, Gallus S, Parpinel M, Franceschi S, Levi FL, Vecchia C. Coffee and tea intake and risk of oral, pharyngeal and esophageal cancer. Oral Oncol 2003; 39:695-700. [PMID: 12907209]
18. Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, Rossing MA. Coffee, tea, colas, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2008; 17:712-6. [PMID: 18349292]
19. Ganmaa D, Willett WC, Li TY, Feskanich D, van Dam RM, Lopez-Garcia E, Hunter DJ, Holmes MD. Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 2008; 122:2071-6. [PMID: 18183588]
20. Can Coffee Lower The Risk of Prostate Cancer?. http:// www.npr.org/templates/story/story.php? storyId=121343438http://www.npr.org/templates/story/ story.php?storyId=121343438
21. Cromie, W. Coffee Gets Cleared of Blood Pressure Risk. Harvard Gazette. 2005. http://www.news.harvard.edu/ gazette/2005/11.10/06-coffee.html http:// www.news.harvard.edu/gazette/2005/11.10/06-coffee.html
22. Lopez-Garcia E. Van dam RM, Willett WC, Rimm EB, Manson JE, Stampfer MJ, Rexrode KM, Hu FB. Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation 2006; 113:2045-53. [PMID: 16636169]
23. Varma SD, Hegde KR. Prevention of oxidative damage to lens by caffeine. J Ocul Pharmacol Ther 2010; 26:73-7. [PMID: 20148663]
24. Varma SD, Hegde KR. Kynurenine induced photo oxidative damage to lens in vitro: Protective effect of caffeine. Mol Cell Biochem 2010; 340:49-54. [PMID: 20204679]
25. Hegde KR, Varma SD, Kovtun S. Protective effect of caffeine against UVR-induced Damage To Neural Retina. ARVO Annual Meeting; 2009 May 3-7; Fort Lauderdale (FL).
26. Varma SD, Hegde KR, Kovtun S. Oxidative stress in lens in vivo: Inhibitory effect of caffeine. A preliminary report. Mol Vis 2010; 16:501-5. [PMID: 20352023]
27. Varma SD, Hegde KR. Effect of α-ketoglutarate against selenite cataract formation. Exp Eye Res 2004; 79:913-8. [PMID: 15642329]
28. Devamanoharan PS, Henein M. Morris, S. Ramachandran, S. Richards, R.D. Varma, SD. Prevention of selenite cataract by vitamin C. Exp Eye Res 1991; 52:563-8. [PMID: 2065724]
29. Varma SD, Hegde KR, Kovtun S. Inhibition of selenite induced cataract by caffeine. Acta Ophthalmol 2010; 88:e245-9. [PMID: 20977689]
30. Varma SD, Mikuni I, Kinoshita JH. Flavonoids as inhibitors of lens aldose reductase. Science 1975; 188:1215-6.
31. Varma SD, Mizuno A, Kinoshita JH. Diabetic cataracts and flavonoids. Science 1977; 195:205-6. [PMID: 401544]
32. Varma SD, Ramachandran S, Devamanoharan PS, Morris SM, Ali AH. Prevention of oxidative damage to rat lens by pyruvate in vitro: possible attenuation in vivo. Curr Eye Res 1995; 14:643-9. [PMID: 8529399]
33. Varma SD, Hegde KR, Henein M. Oxidative damage to mouse lens in culture. Protective effect of pyruvate. Biochim Biophys Acta 2003; 1621:246-52. [PMID: 12787921]
34. Hegde KR, Varma SD. Morphogenetic and apoptotic changes in diabetic cataract. Prevention by pyruvate. Mol Cell Biochem 2004; 262:233-7. [PMID: 15532728]
35. Devasagayam TPA, Kamat JP, Mohan H, Kesavan PC. Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species. Biochim Biophys Acta 1996; 1282:63-70. [PMID: 8679661]
36. Shi X, Dalal NS, Jain AC. Antioxidant behavior of caffeine: efficient scavenging of hydroxyl radicals. Food Chem Toxicol 1991; 29:1-6. [PMID: 1847890]
37. Stadler RH, Fay LB. Antioxidative reactions of caffeine: formation of 8-oxocaffeine (1,3,7 trimethyl uric acid) in coffee subjected to oxidative stress. J Agric Food Chem 1995; 43:1332-8.
38. Varma SD, Chand D, Sharma YR, Kuck JF, Richards RD. Oxidative stress on lens and cataract formation: Role of light and oxygen. Curr Eye Res 1984; 3:35-57. [PMID: 6360540]
39. Zigler JS, Goosey JD. Singlet oxygen as a possible factor in human senile nuclear cataract formation. Curr Eye Res 1984; 3:59-65. [PMID: 6690229]
40. Varma SD, Hegde KR. Prevention of oxidative damage to lens by caffeine. J Ocul Pharmacol Ther 2010; 26:73-7. [PMID: 20148663]
41. Peczon JD, Grans WM. Sedatives, stimulants and intraocular pressure in Glaucoma. Arch Ophthalmol 1964; 72:178-88. [PMID: 14162940]
42. Higginbotham EJ, Kiliminjaro HA, Wilensky JT, Bathenhorst RL, Herman D. The effect of caffeine on intraocular pressure in glaucoma patients. Ophthalmology 1989; 96:624-6.
43. Chandrasekaran S, Rochtchina E, Mitchell P. Effects of caffeine on intraocular pressure. The Blue Mountains Eye Study. J Glaucoma 2005; 14:504-7. [PMID: 16276285]
44. Moura MA, Rodrigues LOC, Wasiberg Y, Almeida HG, Carica ES. Effects of sub maximal exercise with water ingestion on intraocular pressure in healthy human males. Braz J Med Biol Res 2002; 35:121-5. [PMID: 11743624]
45. Drance SM. Studies with applanation water tests. Arch Ophthalmol 1963; 69:39-43.
46. Kang JH, Willett WC, Rosner BA, Hankinson SE, Pasquale LR. Caffeine consumption and the risk of primary open-angle glaucoma: A prospective cohort study. Invest Ophthalmol Vis Sci 2008; 49:1924-31. [PMID: 18263806]
47. Adams BA, Brubaker RF. Caffeine has no clinically significant effect on aqueous humor flow in the normal human eye. Ophthalmology 1990; 97:1030-1. [PMID: 2402413]
48. Linklater HA, Dzialoszynski T, Mcleod HL, Sanford SE, Trevithick JR. Modelong cortical cataractogenesis. X1. Vitammin C reduced gamma crystallin leakage from lenses in diabetic rats. Exp Eye Res 1990; 51:241-7. [PMID: 2401346]
49. Kilic F, Handelman GJ, Traber K, Tsang K, Packer L, Trevtithick JR. Modeling cortical cataractogenesis XX In vitro. Effect of alpha lipoic acid on glutathione concentration in lens in model diabetic cataractognesis. Biochem Mol Biol Int 1998; 46:585-95. [PMID: 9818098]
50. Wang L, Lu L. Pathway specific effect of caffeine on protection against UV irradiation induced apoptosis in corneal epithelial cells. Invest Ophthalmol Vis Sci 2007; 89:318-27. [PMID: 17251462]